CD44 and neoplasm: Some studies have highlighted the importance of high immunohistochemical expression levels of CD133 (prominin-1) as a marker of aggressive tumor characteristics and poorer clinical outcomes [12,13,16,17], while others have identified CD44-positive cells as critical players in tumor progression, influencing both tumor behavior and patient prognosis [18,19,20].